Cipla has received a reaffirmed ‘BUY’ rating from Prabhudas Lilladher following a pivotal regulatory development—the USFDA approval of its generic version of Abraxane (gAbraxane).
Motilal Oswal has reiterated its bullish stance on Prestige Estates Projects Ltd, reaffirming a 'BUY' recommendation with a revised target price of Rs 1,820, implying a substantial upside from curr
Motilal Oswal Financial Services has reaffirmed its BUY recommendation on Indian Hotels Company Ltd. (IHCL), projecting a promising upside in the coming quarters.
Tata Steel's recent investor call brought to light a bold transformation agenda focused on its European operations, particularly through Tata Steel Nederland (TSN).